- xG Technology Inc XGTI shares surged 83.9 percent to $4.23 after the company announced plans to acquire Vislink Communication Systems.
- Globalstar, Inc. GSAT shares rose 41 percent to $1.48 on a Bloomberg article over the weekend saying that the revised Wi-Fi proposal was put on circulation by the FCC.
- Loxo Oncology Inc LOXO shares gained 28.7 percent to $34.63 as the company announced plans for accelerated path to the FDA approval for larotrectinib. The company expects to submit NDA by late 2017 or early 2018.
- Tonix Pharmaceuticals Holding Corp. TNXP shares climbed 23.7 percent to $0.569 after the company disclosed that its PTSD Phase 3-ready drug candidate TNX-102 SL has been given Breakthrough Therapy designation by the FDA.
- Concordia International Corp CXRX gained 15.8 percent to $2.49 after the company issued a business update. The company disclosed that it has paid the 1st installment of its earn-out of £72 million to Cinven related to its acquisition of Amdipharm Mercury. Concordia also terminated its Phase 3 trial for Photodynamic Therapy with Photofrin and eliminated its contract sales team.
- Straight Path Communications Inc STRP shares climbed 14.2 percent to $33.25. Straight Path Communications shares have climbed 42.68 percent over the past 52 weeks, while the S&P 500 index has gained 11.72 percent in the same period.
- Ocular Therapeutix Inc OCUL surged 12.5 percent to $8.94. Ocular Therapeutix shares have dropped 22.44 percent over the past 52 weeks, while the S&P 500 index has gained 11.72 percent in the same period.
- Allied World Assurance Co Holdings, AG. AWH rose 12 percent to $51.26 after Fairfax Financial Holdings Ltd FRFHF agreed to buy the company for $4.9 billion in cash and stock.
- Recro Pharma Inc REPH climbed 11 percent to $7.59. Piper Jaffray initiated coverage on Recro Pharma with an Overweight rating. On Friday, Deerfield Mgmt, L.P. reported a 10.9 percent passive stake in Recro Pharma.
- Brainstorm Cell Therapeutics Inc BCLI gained 7.1 percent to $2.86 after the company disclosed that it has completed a successful end-of-Phase 2 meeting with the FDA.
- DryShips Inc. DRYS shares gained 5.9 percent to $5.20 after dropping 9.07 percent on Friday.
- Lam Research Corporation LRCX rose 3.8 percent to $108.36. Goldman Sachs upgraded Lam Research from Neutral to Buy.
- HubSpot Inc HUBS gained 3.6 percent to $49.10. Raymond James upgraded HubSpot from Outperform to Strong Buy.
- Lennar Corporation LEN shares rose 3 percent to $44.74 after the company posted stronger-than-expected earnings for its fourth quarter on Monday.
- DexCom, Inc. DXCM shares gained around 3 percent to $65.12. Oppenheimer upgraded DexCom from Perform to Outperform.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In: NewsIntraday UpdateMarketsAnalyst RatingsMoversConsumer DiscretionaryHomebuildingInformation TechnologySemiconductor EquipmentTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
